克罗恩病临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 克罗恩病（国际通用名 Crohn disease）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖克隆氏病、炎症性肠病等说法。

正在招募的克罗恩病新药试验

• 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease

  早期 I 期招募中美国NCT07273188

• Microbial Restoration in Inflammatory Bowel Diseases

  I 期 / II 期招募中澳大利亚NCT04970446

• Treatment of Moderate to Severe Refractory Crohn's Disease

  I 期 / II 期招募中美国NCT06721962

• Therapeutic Endpoint in Pediatric IBD Conditions

  不适用招募中美国NCT06065228

• Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives

  不适用招募中意大利NetherlandsPolandPortugalNCT07316621

• Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

  不适用招募中英国NCT07522528

• Intestinal Organoids

  不适用招募中法国NCT05294107

• Registry and Biorepository for IBD in Central Texas

  不适用招募中美国NCT04617184

• Endoscopic Severity Image Recognition to Advance Research and Training in Inflammatory Bowel Disease (EVEREST - IBD)

  不适用招募中英国NCT04867408

• Post-Operative Crohn's Disease Outcome in Children

  不适用招募中IsraelNCT03681652

• Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

  IV 期招募中中国NCT07216014

• Body Composition Assessment and Monitoring in Inflammatory Bowel Disease

  不适用招募中西班牙NCT07162701